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Diffuse low-grade gliomas (DLGG) are slow-growing brain tumors that in spite of an indo-
lent behavior at onset show a continuous expansion over time and inevitably transform
into malignant gliomas. Extensive tumor resections may be performed with preservation
of neurological function due to neuroplasticity that is induced by the slow tumor growth.
However, DLGG prefer to migrate along subcortical pathways, and white matter plasticity
is considerably more limited than gray matter plasticity. Whether signs of functional
decompensating white matter that may be found as early as at disease presentation
has not been systematically studied. Here, we examined 52 patients who presented
with a DLGG at the time of radiological diagnosis. We found a significant correlation
between neurological impairment and eloquent cortico-subcortical tumor localization, but
not between neurological function and tumor volume. These results suggest that even
small tumors invading white matter pathways may lack compensatory mechanisms for
functional reorganization already at disease presentation.
Keywords: low-grade gliomas, neurological function, professional situation, tumor volume, tumor location, brain
plasticity, radiological diagnosis
Introduction
Diffuse low-grade gliomas (DLGG) are slow growing primary brain tumors occurring mainly in
young adults. DLGG are classified as gliomas WHO (World Health Organization) Grade II and
characterized by extensive invasion but low proliferation (1). In spite of advances in diagnostic
methods and surgical techniques, allowing extensive and safe tumor resections as well as the
introduction of molecular tumor markers guiding therapeutic decisions, the clinical management
of DLGG remains challenging (2). Sequential magnetic resonance imaging (MRI) studies of DLGG
have demonstrated a linear growth in diameter of the bulky tumor mass before first-line treatment
(3). In parallel with a continuous expansion over time, DLGG migrate along the white matter
pathways where the invasion rate is estimated to be about five times higher than in the gray
matter (4).
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Around 70–90% of all patients with DLGG present with epilep-
tic seizures and epilepsy may be the only symptom during the
initial years after diagnosis (5). Some patients, however, may
have focal neurological signs or cognitive impairment already at
disease presentation. In general, impaired function in patients
with brain tumors can be induced by compression of brain struc-
tures, either directly or indirectly by reactive edema. Additional
factors affecting cognition are uncontrolled seizures, side effects of
anticonvulsant treatment, and psychological distress due to brain
tumor diagnosis (6).
Optimal functioning of the brain depends on intact neuro-
logical, cognitive, and affective function and is determined by
the anatomic and physiological integrity of complex cerebral net-
works (7). The complex interactions between the tumor and the
host brain are still not well understood. There is growing evidence
that loss of neuronal network integrity in patients with brain
tumors has a negative impact on cerebral function and decreases
the threshold to develop seizures (8). The degree of functional loss
appears to be related to the growth rate of the tumor, i.e., fast grow-
ing tumors causemore profound loss than slowly growing tumors.
Brain plasticity most commonly refers to adaptive changes in
neural pathways, synapses, and glial cells, leading to functional
or morphological reorganization. Numerous surgical studies have
provided support for that DLGG induce brain plasticity through
functional compensation and reorganization of the cortex (9).
In addition to gray matter plasticity, the subcortical pathways
play a crucial role in shaping cortical reorganization (10). This
concept is exemplified by the fact that large tumor resections have
been performed without inducing functional loss, as long as the
network connectivity is preserved (11). It is generally accepted
though that the plasticity of the white matter is considerably more
limited than that of the gray matter (11).
DLGG are diagnosed at various steps along the continuum
of their natural course, which has been proposed to occur
as a three-step process; an initial silent period, followed by a
symptomatic period, and a final period of malignant progres-
sion (12, 13). In the silent phase when tumor diagnosis is still
unknown, tumor-related symptoms may be present but not rec-
ognized (14). Subtle disease-related symptoms at such an early
phase might nevertheless have an impact on daily life activi-
ties, including professional life. In this study, we hypothesized
that patients with tumors invading white matter structures carry
a risk for impairment of neurological function already at dis-
ease presentation. In other words, tumors in eloquent areas
affecting subcortical pathways may cause earlier loss of func-
tion than tumors with strictly cortical location, irrespective of
tumor volume. To test this hypothesis, we studied a cohort of
52 patients with DLGG at the time of radiological diagnosis and
correlated their clinical parameters to tumor volume and tumor
location.
Materials and Methods
Patients
Consecutive patients (18 years) presenting with a suspected
DLGG at the Department of Neurosurgery, Uppsala University
Hospital were enrolled during two time periods. Twenty-four
patients were recruited between 2005 and 2008 from an ongoing
multicenter glioma study at our hospital (15) and 28 patients were
recruited between 2011 and 2013 from a previously described
cohort ofDLGG (16). The studymethodologywas similar for both
patient groups andbaseline clinical characteristics (mean age, gen-
der, presenting symptoms) did not differ significantly, allowing
pooling of data. The institutional review board approved the study
protocols and written informed consent was obtained prior to
participation. Initial inclusion criteria were morphological MRI
findings suggestive of a DLGG, based on typical appearance
with high signal intensity on fluid attenuated inversion recovery
(FLAIR) sequence and a T1-weighted sequence showing no or
only patchy and faint contrast enhancement. Inclusion criteria
by central pathology review were gliomas WHO grade II (1),
leaving a final study sample of 52 tumors (23 astrocytomas, 8
oligoastrocytomas, and 21 oligodendrogliomas).
Assessment of Neurological Function and
Seizure Control
Within 3months from radiological tumor diagnosis, the neurolo-
gist performed neurological examination with special attention to
language, motor and sensory function, visual fields, and cognitive
function. Neurological function was rated according to the Radi-
ation Therapy Oncology Group (RTOG) Neurological Function
Status, as follows (17): 0= no neurological symptoms; 1=minor
neurological symptoms; 2=moderate neurological symptoms,
fully active at work/home but requiring assistance; 3=moderate
neurological symptoms, less than fully active at home/work and
requiring assistance; 4= severe neurological symptoms, totally
inactive requiring complete assistance at home or in institution –
unable to work.
In connection with neurological examination, patients com-
pleted a questionnaire on the type of first symptoms and,
in case of seizures, on seizure control during the previous
2months. The burden of epilepsy was estimated taking into
account the frequency of seizures during these 2months and
the number of antiepileptic drugs (AED), and rated as previ-
ously described with slight modification (18): 1= no epilepsy;
2= epilepsy but seizure-free without AED; 3= epilepsy but
seizure-free on AED; 4= epilepsy with fewer than three seizures
on AED; 5= epilepsy with at least three seizures on monother-
apy with AED, and 6= epilepsy with at least three seizures on
polytherapy with AED.
Assessment of Changes in Professional Life
Patients were asked to report their educational background, pro-
fession, and any changes in professional situation during the
year preceding radiological diagnosis, according to a battery with
standardized questions. Based on the number of years and level
of higher education, patients were divided into three groups:
retired (n= 8), professions requiring higher education (n= 19),
and lower skilled professions (n= 18) (Table 1). Among higher
educated patients, there were university professors, biologists,
computer designers, optician, university students, clerk, teacher,
businessmen, nurses, andmarketingmanagers. Lower skilled pro-
fessions comprised electricians, carpenters, construction workers,
home care and hospital assistants, and housekeepers.
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TABLE 1 | Patient and tumor characteristics of the cohort (n=52).
Number (%) MeanSD Range
Patient characteristics
Age (year) 52 44.814 22–78
Gender
Male 34
Female 18
Seizures at presentation 38 (73.1%)
Antiepileptic drugs 37
Seizure-free 20
Recurrent seizure 18
No seizures at presentation 14 (29.9%)
Neurological function (RTOG) 52 1.191.15 0–3
No neurological symptoms 17 (32.7%)
Minor neurological symptoms 21 (40.4%)
Moderate neurological symptoms 14 (26.9%)
Professions (n= 52)
High education 26 (50%)
Low education 18 (34.6%)
Retired 8 (15.4%)
Work situation (n= 52)
Working fully 25 (48%)
Working half time 11 (21%)
Not working, due to illness 4 (8%)
Retired, unrelated to illness 8 (15%)
Students 2 (4%)
Unemployed 2 (4%)
Changes in professional situation 19 (36%)
Tumor characteristics
Affected hemisphere
Right 20 (38.5%)
Left 31 (38.5%)
Bilateral 1 (1.9%)
Tumor location 52
Non-eloquent cortex 8
Non-eloquent cortico-subcortical 12
Eloquent cortico-subcortical 32
Insula 9
SMAa/Pre SMA 5/2
Primary somatosensory area 6
Primary motor area 4
Language area 6
Tumor volume (cm3) 50 69.357.3 2.8–267.8
Smaller (<61 cm3) 24
Larger (>61 cm3) 26
aSupplementary motor area.
Tumor Volume
Aneuroradiologist blinded for patient data evaluated all preopera-
tiveMRI examinations. In-house developed software was used for
tumor delineation. Most DLGG appeared as an area of high signal
intensity without surrounding edema on the FLAIR sequence.
The entire area with high signal intensity was regarded as tumor
tissue. Contours were manually drawn on FLAIR images in all
slices showing visible tumor. The calculated tumor volume (cubic
centimeter) was derived from the number of voxels defined as
tumor multiplied with the voxel size of the image set.
Tumor Location
Tumor location was evaluated on preoperative MRI including
T1-weighted images before and after gadolinium-based contrast
enhancement, T2-weighted and FLAIR sequences. Locations were
defined as mainly cortical or cortical with subcortical affection
(=cortical/subcortical). Tumor location was further specified as
eloquent or non-eloquent regions, as previously described (20).
Eloquent areas consisted of insula, language areas, visual cor-
tex, supplementary motor area (SMA), primary motor area, and
sensorimotor area. Non-eloquent areas included regions in the
non-dominant hemisphere, i.e., right frontopolar/prefrontal area,
premotor cortex/frontal operculum, anterior/midtemporal area,
and right parieto-temporo-occipital junction. Frontal and tem-
poral pole in the left or dominant hemisphere were considered
non-eloquent.
Statistical Analysis
Descriptive analysis and pie charts were used to assess patient-
and tumor-related parameters. Median split was used to turn
the continuous volume data into a categorical one (small versus
large volume). Analysis of the correlation between tumor vol-
ume respectively tumor location with neurological function and
seizure control was performed by Spearman correlation test. A
P value <0.05 was considered statistically significant. Statistical
analysis was performed using IBM SPSS Inc. (version 21).
Results
Neurological Function and Seizure Control
The clinical characteristics of the study sample are shown in
Table 1. The distribution of neurological function, seizure as first
symptoms, and seizure control is illustrated in the Figure S1 in
Supplementary Material. Most patients had no or minor neuro-
logical symptoms (RTOG scale 0–1). Epileptic seizures as initial
symptomwere present in 38 patients (73.1%). Of these patients, all
but one was on AED; 20 patients were seizure-free during the last
2months. Thus, 18 patients had recurrent seizures of which seven
patients with less than three seizures; 11 patients had at least three
seizures despite monotherapy (n= 6) or polytherapy (n= 5) with
AED. Fourteen patients (26.9%) had other neurologic symptoms
as presenting symptom; five presented with dizziness, four with
headache, one with paresis, and two with dysphasia and memory
disturbances. Two patients had incidentally discovered tumors.
Changes in Professional Situation
At the time of radiological diagnosis, 25 patients were fully at
work (48%), 11 half time at work (21%), 2 full-time students
(4%), 2 unemployed (4%), 8 retired (15%), and 4 (8%) unable
to work due to disease-related symptoms (Table 1). Regarding
changes in work situation during the year preceding radiological
tumor diagnosis, 19 patients (36%) reported adjusted workload
(n= 8), reduction from full-time to half time (n= 7), or full-
time sick leave (n= 4) (illustrated in Figure S1 in Supplementary
Material). There was a significant correlation between change
in professional situation (reduced/altered work situation, n= 19
versus unchanged/unrelated, n= 33) and neurological function
(moderate symptoms, n= 14 versus no/minor symptoms, n= 38)
(Spearman’s r= 0.40, P= 0.008), but not between change in pro-
fessional situation and seizure control (recurrent seizures, n= 18
versus no seizures/seizure-free, n= 34).
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Tumor Volume
Digital images were missing in two cases and volume was mea-
sured in 50/52 patients. Mean volume was 69.30 57.34 cm3
(median 60.69 cm3, range 2.77–267.77 cm3). There was no signif-
icant correlation between tumor volume, neither as continuous
data nor as median split values (61 cm3 versus >61 cm3) with
neurological function or with seizure control (data not shown).
Tumor Location
The specific tumor location is shown in Table 1. In summary,
only eight tumors showed mainly cortical location, all situated
in non-eloquent areas (illustrated in Figure 1A). A total of 32
tumors were situated in eloquent areas, while 20 tumors were
found in non-eloquent areas. Of the 32 tumors in eloquent
areas, all invaded both cortical and subcortical regions (cortico-
subcortical location, illustrated in Figure 1B). Tumors in
non-eloquent regions invaded frontopolar/prefrontal cortex
(n= 11), anterior/midtemporal region (n= 4), right parieto-
occipital area (n= 2), and right premotor cortex/frontal
operculum (n= 3) (Table 1). There was a significant correlation
between tumor location and neurological function when dividing
tumors in eloquent cortico-subcortical (n= 32) versus non-
eloquent cortico-subcortical/non-eloquent mainly cortical
(n= 12+ 8= 20) location. Thus, eloquent cortico-subcortical
tumor location was correlated with impaired neurological
function (Spearman’s r= 0.280, P= 0.049) in the cohort. We
found no significant correlation between tumor location and
seizure control (data not shown).
Discussion
The invaded brain tissue is often regarded as a homogeneous and
passive tissue modified by the tumor in a unidirectional manner.
However, the slow growth and invasion of the tumor induce
reciprocal processes and multiple active and passive mechanisms
in the surrounding tissue (21). Consequently, patients with DLGG
can undergo massive cerebral resections with significantly better
neurological recovery than after acute brain injuries (22). In the
present study, we evaluated neurological function and seizure
control at the time of radiological diagnosis in correlation with
tumor volume and tumor location. Such easily available radiolog-
ical parameters may predict the clinical function of this patient
group, in parallel with other neurological disorders such as stroke
or traumatic brain lesions. We found a significant correlation
between neurological impairment and tumor location in eloquent
cortico-subcortical areas. By contrast, the grade of neurological
symptoms in our cohort was not correlated with tumor volume.
Our findings are consistent with the concept that reorganiza-
tion of networks occurs in the silent phase of DLGG, and that
tumors invading the white matter may lack such compensatory
mechanisms at early phase of disease (23).
For rating of neurological function, we used the RTOG Neu-
rological Function Scale, which is a widely used but blunt instru-
ment. We also recorded changes in professional situation during
the year preceding brain tumor diagnosis, such as adjustments
in work tasks or reduced workload. From a clinical perspec-
tive, the latter parameter may present an indirect indicator for
FIGURE 1 | (A) MRI FLAIR sequence showing a left frontal astrocytoma
grade II located in a non-eloquent area with mainly cortical location, in a
38-year-old female. (B) MRI FLAIR sequence showing an insular
oligodendroglioma grade II, located affecting cortical and subcortical regions,
in a 27-year-old male.
tumor-related symptoms for the patient. Interestingly, a high
proportion of patients (36%) in our cohort encountered a change
in professional situation during the year prior to tumor diagnosis.
This percentage is higher than what is to be expected in the
normal working population in our country (24). These findings
suggest that reduced or lost professional capacity due to disease-
related symptoms may precede radiological tumor diagnosis and
underscore the importance of evaluating this aspect at first visit to
the clinic. Our results also argue for early diagnostic intervention
of individuals with slow onset difficulties to cope with work
or studies without any clear explanatory factors. There was no
difference in professional situation between patients with high-
and low-skilled professions, which may reflect the relatively small
numbers in the different subgroups. In this context, it is important
to bear in mind that our study is based on limited clinical data
and that the data presented here are preliminary findings that
need confirmation in larger studies. This is also exemplified by
the cutoff value for tumor volume (61 cm3) calculated by using
median split, which is relatively small compared to what is known
from the European Organization for Research and Treatment of
Cancer (EORTC) trials on DLGG (25).
One study so far has demonstrated that impairment of specific
neurological function is an indicator for the professional reinte-
gration of patients with DLGG (26). In contrast to patients with
normal language function after tumor resection in language areas,
those with impaired lexicon access speed were not able to return
to work (26). Since neuropsychological test results were available
only for a small subset of patients, these data could not be included
in our analysis. The lack of neuropsychological test results is an
obvious limitation of the present study and, together with the
small sample size, a strong argument for the need of future trials
including specific cognitive test batteries (19).
Epileptic seizures were the first tumor manifestation in the
majority of patients in this study and all but one patient with
seizures were on AED. In agreement with a recent multicen-
ter study including 1509 patients, we did not find a correlation
between tumor volume and seizure control (5). Only 11 patients
in our cohort had more than three seizures during the previous
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2months, of whom five used at least two AED. The relatively
good seizure control may reflect the early phase of the disease
but also better compliance for new generation AED compared to
older AED. Most patients in our cohort were on new AED such as
levetiracetam and lamotrigine that are now routinely used in the
brain tumor population because of their favorable adverse effect
profile (27).
In conclusion, the data presented here show that patients with
DLGG in eloquent areas invading subcortical pathways may be
at risk for neurological impairment already at the time of radio-
logical diagnosis. Our findings warrant well-designed future trials
evaluating neurological and cognitive function in this early phase
of the disease.
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